Grace Therapeutics, Inc.
GRCE· Nasdaq
GRCEGrace Therapeutics, Inc.
Filed Jun 29, 2020 · 10-K · 90 days after period end · 0001171843-20-004613
| Metric | Q4 2020 | Q4 2019 |
|---|---|---|
| Net Income | -$25.51M | -$39.37M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Grace Therapeutics, Inc. · CIK 1444192 · Engraved from SEC EDGAR
ended Mar 31, 2020 · filed Jun 29, 2020 · 90 d after period end
